Bacillus minimum genome factory: Effective utilization of microbial genome information

Katsutoshi Ara, Katsuya Ozaki, Kouji Nakamura, Kunio Yamane, Junichi Sekiguchii, Naotake Ogasawara

Research output: Contribution to journalShort survey

76 Citations (Scopus)

Abstract

In 1997, the complete genomic DNA sequence of Bacillus subtilis (4.2 Mbp) was determined and 4100 genes were identified [Kunst, Ogasawara, Moszer, Albertini, Alloni, Azevedo, Bertero, Bessieres, Bolotin, Borchert, S. et al. (1997) Nature 90, 249-256]. In addition, B. subtilis, which shows an excellent ability to secrete proteins (enzymes) and antibiotics in large quantities outside the cell, plays an important role in industrial and medical fields. It is necessary to clarify the genes involved in the production of compounds by understanding the network of these 4100 genes and the proceeding analysis of genes of unknown functions. In promoting such a study, it is expected that the regulatory system of B. subtilis can be simplified by the creation of a Bacillus strain with a reduced genome by discriminating genes unnecessary for the production of proteins from essential genes, and deleting as many of these unnecessary genes as possible, which may help to understand this complex network of genes. We have previously distinguished essential and non-essential genes by evaluating the growth and enzyme-producing properties of strains of B. subtilis in which about 3000 genes (except 271 essential genes) have been disrupted or deleted singly, and have successfully utilized the findings from these studies in creating the MGIM strain with an approx. I Mbp deletion by serially deleting 17 unnecessary regions from the genome. This strain showed slightly reduced growth in enzyme-production medium, but no marked morphological changes. Moreover, we confirmed that the MGIM strain had cellulase and protease productivity comparable with that of the B. subtilis 168 strain, thus demonstrating that genome reduction does not contribute to a negative influence on enzyme productivity.

Original languageEnglish
Pages (from-to)169-178
Number of pages10
JournalBiotechnology and Applied Biochemistry
Volume46
Issue number3-4
DOIs
Publication statusPublished - 2007 Apr 1
Externally publishedYes

Fingerprint

Microbial Genome
Bacilli
Bacillus
Industrial plants
Genes
Bacillus subtilis
Genome
Gene Regulatory Networks
Essential Genes
Enzymes
Cellulase
Growth
Proteins
Peptide Hydrolases
Productivity
Anti-Bacterial Agents
DNA sequences
Complex networks
Antibiotics

Keywords

  • Bacillus subtilis
  • Genome analysis and reduction
  • Heterologous protein production
  • Host micro-organism
  • Minimum genome factory (MGF)

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Molecular Medicine
  • Biomedical Engineering
  • Applied Microbiology and Biotechnology
  • Drug Discovery
  • Process Chemistry and Technology

Cite this

Bacillus minimum genome factory : Effective utilization of microbial genome information. / Ara, Katsutoshi; Ozaki, Katsuya; Nakamura, Kouji; Yamane, Kunio; Sekiguchii, Junichi; Ogasawara, Naotake.

In: Biotechnology and Applied Biochemistry, Vol. 46, No. 3-4, 01.04.2007, p. 169-178.

Research output: Contribution to journalShort survey

Ara, Katsutoshi ; Ozaki, Katsuya ; Nakamura, Kouji ; Yamane, Kunio ; Sekiguchii, Junichi ; Ogasawara, Naotake. / Bacillus minimum genome factory : Effective utilization of microbial genome information. In: Biotechnology and Applied Biochemistry. 2007 ; Vol. 46, No. 3-4. pp. 169-178.
@article{61f4294d757a484f9427bd8006679561,
title = "Bacillus minimum genome factory: Effective utilization of microbial genome information",
abstract = "In 1997, the complete genomic DNA sequence of Bacillus subtilis (4.2 Mbp) was determined and 4100 genes were identified [Kunst, Ogasawara, Moszer, Albertini, Alloni, Azevedo, Bertero, Bessieres, Bolotin, Borchert, S. et al. (1997) Nature 90, 249-256]. In addition, B. subtilis, which shows an excellent ability to secrete proteins (enzymes) and antibiotics in large quantities outside the cell, plays an important role in industrial and medical fields. It is necessary to clarify the genes involved in the production of compounds by understanding the network of these 4100 genes and the proceeding analysis of genes of unknown functions. In promoting such a study, it is expected that the regulatory system of B. subtilis can be simplified by the creation of a Bacillus strain with a reduced genome by discriminating genes unnecessary for the production of proteins from essential genes, and deleting as many of these unnecessary genes as possible, which may help to understand this complex network of genes. We have previously distinguished essential and non-essential genes by evaluating the growth and enzyme-producing properties of strains of B. subtilis in which about 3000 genes (except 271 essential genes) have been disrupted or deleted singly, and have successfully utilized the findings from these studies in creating the MGIM strain with an approx. I Mbp deletion by serially deleting 17 unnecessary regions from the genome. This strain showed slightly reduced growth in enzyme-production medium, but no marked morphological changes. Moreover, we confirmed that the MGIM strain had cellulase and protease productivity comparable with that of the B. subtilis 168 strain, thus demonstrating that genome reduction does not contribute to a negative influence on enzyme productivity.",
keywords = "Bacillus subtilis, Genome analysis and reduction, Heterologous protein production, Host micro-organism, Minimum genome factory (MGF)",
author = "Katsutoshi Ara and Katsuya Ozaki and Kouji Nakamura and Kunio Yamane and Junichi Sekiguchii and Naotake Ogasawara",
year = "2007",
month = "4",
day = "1",
doi = "10.1042/BA20060111",
language = "English",
volume = "46",
pages = "169--178",
journal = "Biotechnology and Applied Biochemistry",
issn = "0885-4513",
publisher = "Wiley-Blackwell",
number = "3-4",

}

TY - JOUR

T1 - Bacillus minimum genome factory

T2 - Effective utilization of microbial genome information

AU - Ara, Katsutoshi

AU - Ozaki, Katsuya

AU - Nakamura, Kouji

AU - Yamane, Kunio

AU - Sekiguchii, Junichi

AU - Ogasawara, Naotake

PY - 2007/4/1

Y1 - 2007/4/1

N2 - In 1997, the complete genomic DNA sequence of Bacillus subtilis (4.2 Mbp) was determined and 4100 genes were identified [Kunst, Ogasawara, Moszer, Albertini, Alloni, Azevedo, Bertero, Bessieres, Bolotin, Borchert, S. et al. (1997) Nature 90, 249-256]. In addition, B. subtilis, which shows an excellent ability to secrete proteins (enzymes) and antibiotics in large quantities outside the cell, plays an important role in industrial and medical fields. It is necessary to clarify the genes involved in the production of compounds by understanding the network of these 4100 genes and the proceeding analysis of genes of unknown functions. In promoting such a study, it is expected that the regulatory system of B. subtilis can be simplified by the creation of a Bacillus strain with a reduced genome by discriminating genes unnecessary for the production of proteins from essential genes, and deleting as many of these unnecessary genes as possible, which may help to understand this complex network of genes. We have previously distinguished essential and non-essential genes by evaluating the growth and enzyme-producing properties of strains of B. subtilis in which about 3000 genes (except 271 essential genes) have been disrupted or deleted singly, and have successfully utilized the findings from these studies in creating the MGIM strain with an approx. I Mbp deletion by serially deleting 17 unnecessary regions from the genome. This strain showed slightly reduced growth in enzyme-production medium, but no marked morphological changes. Moreover, we confirmed that the MGIM strain had cellulase and protease productivity comparable with that of the B. subtilis 168 strain, thus demonstrating that genome reduction does not contribute to a negative influence on enzyme productivity.

AB - In 1997, the complete genomic DNA sequence of Bacillus subtilis (4.2 Mbp) was determined and 4100 genes were identified [Kunst, Ogasawara, Moszer, Albertini, Alloni, Azevedo, Bertero, Bessieres, Bolotin, Borchert, S. et al. (1997) Nature 90, 249-256]. In addition, B. subtilis, which shows an excellent ability to secrete proteins (enzymes) and antibiotics in large quantities outside the cell, plays an important role in industrial and medical fields. It is necessary to clarify the genes involved in the production of compounds by understanding the network of these 4100 genes and the proceeding analysis of genes of unknown functions. In promoting such a study, it is expected that the regulatory system of B. subtilis can be simplified by the creation of a Bacillus strain with a reduced genome by discriminating genes unnecessary for the production of proteins from essential genes, and deleting as many of these unnecessary genes as possible, which may help to understand this complex network of genes. We have previously distinguished essential and non-essential genes by evaluating the growth and enzyme-producing properties of strains of B. subtilis in which about 3000 genes (except 271 essential genes) have been disrupted or deleted singly, and have successfully utilized the findings from these studies in creating the MGIM strain with an approx. I Mbp deletion by serially deleting 17 unnecessary regions from the genome. This strain showed slightly reduced growth in enzyme-production medium, but no marked morphological changes. Moreover, we confirmed that the MGIM strain had cellulase and protease productivity comparable with that of the B. subtilis 168 strain, thus demonstrating that genome reduction does not contribute to a negative influence on enzyme productivity.

KW - Bacillus subtilis

KW - Genome analysis and reduction

KW - Heterologous protein production

KW - Host micro-organism

KW - Minimum genome factory (MGF)

UR - http://www.scopus.com/inward/record.url?scp=34247141488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247141488&partnerID=8YFLogxK

U2 - 10.1042/BA20060111

DO - 10.1042/BA20060111

M3 - Short survey

C2 - 17115975

AN - SCOPUS:34247141488

VL - 46

SP - 169

EP - 178

JO - Biotechnology and Applied Biochemistry

JF - Biotechnology and Applied Biochemistry

SN - 0885-4513

IS - 3-4

ER -